Xenon Pharmaceuticals Inc. (XENE) SEC Filings — 2025
13 SEC filings for Xenon Pharmaceuticals Inc. (XENE) in 2025.
Filings
- Xenon Pharmaceuticals Files 8-K on Officer/Director Changes — 8-K · Dec 1, 2025
- Xenon's Losses Widen 43% Amid Soaring R&D Costs — 10-Q · Nov 3, 2025
- Xenon Pharmaceuticals Files 8-K/A Amendment — 8-K/A · Oct 17, 2025
- Xenon Pharmaceuticals Announces Board and Officer Changes — 8-K · Oct 16, 2025
- Xenon Continues R&D Spend, No Revenue in Q2 — 10-Q · Aug 11, 2025
- Xenon Pharmaceuticals Announces Executive and Board Changes — 8-K · Jul 3, 2025
- Xenon Pharmaceuticals Files 8-K on Shareholder Votes & Exhibits — 8-K · Jun 5, 2025
- Xenon Pharma Files Q1 2025 10-Q — 10-Q · May 12, 2025
- Xenon Pharma Executive Compensation Details Revealed — DEF 14A · Apr 24, 2025
- Xenon Pharmaceuticals Files 8-K — 8-K · Mar 17, 2025
- Xenon Pharmaceuticals Changes Auditor to Ernst & Young LLP — 8-K · Mar 5, 2025
- Xenon Pharmaceuticals Files 2024 10-K — 10-K · Feb 27, 2025
- Xenon Pharmaceuticals Reports Director and Officer Changes — 8-K · Jan 17, 2025